Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa
Health

Greenwich LifeSciences reports 83% reduction in breast cancer recurrence in Phase III trial

Greenwich LifeSciences (NASDAQ:GLSI) released a preliminary update from its ongoing Phase III FLAMINGO-01 clinical trial, which evaluates the efficacy of GP2, an immunotherapy designed to prevent breast cancer recurrences.

Leia mais: Greenwich LifeSciences reports 83% reduction in breast cancer recurrence in Phase III trial